Assured Guaranty: Chapter 9s could force pullback
* Cites Harrisburg, Jefferson County filings
* Calls trend "disturbing"
Nov 15 (Reuters) - Bond insurer Assured Guaranty (AGO.N) may stop underwriting bonds in states without tighter controls on municipal bankruptcies, after two recent high-profile filings, the company's chief executive said on Tuesday.
Assured is the last active insurer of municipal bonds in the United States, after the financial crisis struck down most of its competitors. But the company said Tuesday there were "disturbing trends" of late in local government bankruptcies that had it reconsidering some of its book of business.
"We will reconsider insuring any municipality in states that do not have a framework in place to review and approve local bankruptcy petitions," Chief Executive Dominic Frederico said on a conference call with analysts.
The company cited two recent filings in particular: the Pennsylvania capital Harrisburg and Jefferson County, Alabama, both of which have been highly contentious.
There are questions about whether either had the right to file for Chapter 9 bankruptcy protection, given state laws that may interfere.
Municipal bond insurance is often used to help borrowers obtain more favorable terms by adding the insurer's guarantee. Assured Guaranty, which no longer has an "AAA" credit rating, has said its backing can still help smaller and lower-rated entities come to market affordably. (Reporting by Ben Berkowitz, editing by Dave Zimmerman)
- Tweet this
- Share this
- Digg this
- UPDATE 2-Malaysia Airlines loses contact with plane carrying 239 people
- UPDATE 3-U.S. FDA probes cognitive impact of new cholesterol drugs
- Malaysia Airlines loses contact with plane carrying 239 people
- UPDATE 3-Boeing reports wing cracks on 787 Dreamliners in production
- No signal picked up from missing Malaysia Airlines plane - Vietnam official
Drug maker Ranbaxy Laboratories Ltd has recalled more than 64,000 bottles of the generic versions of its cholesterol-lowering drug in the United States due to reports of a dose mix-up, U.S. regulators said. Full Article